1
|
Nakazawa E, Shaw MH, Akabayashi A. The Ethical Acceptability of a Recipient's Choice of Donor in Directed and Nondirected Transplantation: Japanese Perspective. Camb Q Healthc Ethics 2022; 32:1-6. [PMID: 36330827 DOI: 10.1017/s0963180122000214] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
In organ transplantation, there is a lack of ethical discussion about the recipient's right not to receive a transplant. Using the current situation of living organ transplantation and deceased organ transplantation in Japan as an example, we prospectively discussed to what extent the recipient's right not to receive a transplant is ethically acceptable. In directed transplantation from a living donor, a recipient may refuse organ donation from a particular donor. It is preferable that a recipient's request for organ donation from a donor occurs as part of a transparent process. In nondirected transplantation from a deceased donor, refusal of transplantation from a particular type of donor appears potentially justifiable. There are both moral and pragmatic considerations. Certain refusals based solely on belief are morally unacceptable, and refusal to transplant a recipient based on the donor's age jeopardizes the entire transplant system. When religious beliefs affect mental and physical health, individualized measures are required for transplant rejection. We also deductively developed a prospective argument based on the current status of donor-recipient communication in living organ transplantation in Japan and the 2010 amendment of the law allowing relatives to be given priority in organ transplantation from deceased donors.
Collapse
Affiliation(s)
- Eisuke Nakazawa
- Department of Biomedical Ethics, School of Public Health, Faculty of Medicine, The University of Tokyo, Tokyo, Japan
| | - Margie H Shaw
- Department of Health Humanities and Bioethics, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
| | - Akira Akabayashi
- Department of Biomedical Ethics, School of Public Health, Faculty of Medicine, The University of Tokyo, Tokyo, Japan
- Division of Medical Ethics, New York University School of Medicine, New York, New York, USA
| |
Collapse
|
2
|
Vali S, Jones BP, Saso S, Fertleman M, Testa G, Johanesson L, Alghrani A, Smith JR. Uterine transplantation: legal and regulatory implications in England. BJOG 2021; 129:590-596. [PMID: 34532958 DOI: 10.1111/1471-0528.16927] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/27/2021] [Indexed: 12/01/2022]
Abstract
Uterus transplantation (UTx) is fast evolving from an experimental to a clinical procedure, combining solid organ transplantation with assisted reproductive technology. The commencement of the first human uterus transplant trial in the United Kingdom leads us to examine and reflect upon the legal and regulatory aspects closely intertwined with UTx from the process of donation to potential implications for fertility treatment and the birth of the resultant child. As the world's first ephemeral transplant, the possibility of organ restitution requires consideration and is discussed herein. TWEETABLE ABSTRACT: Uterine transplantation warrants a closer look at the legal frameworks on fertility treatment and transplantation in England.
Collapse
Affiliation(s)
- S Vali
- Department of Surgery and Cancer, Hammersmith Hospital, Imperial College London, London, UK.,Cutrale Perioperative and Ageing Research Group, Imperial College London, London, UK
| | - B P Jones
- Department of Surgery and Cancer, Hammersmith Hospital, Imperial College London, London, UK.,West London Gynaecological Cancer Centre, Hammersmith Hospital, Imperial College NHS Trust, London, UK
| | - S Saso
- Department of Surgery and Cancer, Hammersmith Hospital, Imperial College London, London, UK.,West London Gynaecological Cancer Centre, Hammersmith Hospital, Imperial College NHS Trust, London, UK
| | - M Fertleman
- Cutrale Perioperative and Ageing Research Group, Imperial College London, London, UK
| | - G Testa
- Baylor University Medical Centre, Dallas, TX, USA
| | - L Johanesson
- Baylor University Medical Centre, Dallas, TX, USA
| | - A Alghrani
- School of Law and Social Justice, University of Liverpool, Liverpool, UK
| | - J R Smith
- Department of Surgery and Cancer, Hammersmith Hospital, Imperial College London, London, UK.,West London Gynaecological Cancer Centre, Hammersmith Hospital, Imperial College NHS Trust, London, UK
| |
Collapse
|